REFERENCES
- Ebeling P., Koivisto V. A. Lancet 1994; 343: 1479
- Vermeulen A. Dehydroepiandrosterone (DHEA) sulfate and aging. Ann. NY Acad. Sci. 1995; 774: 121
- Labrie C., Falmand M., Bélanger A., Labrie F. J. Endocrinol. 1996; 150: S107
- Diamond P., Cusan L., Gomez J. L., Bélanger A., Labrie F. J. Endocrinol. 1990; 150: 543
- Hadgraft J. Int. J. Pharm. 1999; 184: 1
- Chiang, et al., U.S. Pat. 4973468, November 27 1990
- Okabe H., Takayama K., Ogura A., Nagai T. Drug Design Deliv. 1989; 4: 313
- Okamoto H., Muta K., Hashida M., Sezaki H. Pharm. Res. 1990; 7: 64
- Walters K. A., Walker M., Olejnik O. J. Pharm. Pharmacol. 1988; 40: 525
- Uniformity content of single-dose preparations. European Pharmacopoiea. 3rd Ed., 1977; 134
- Bronaugh R. L., Maibach H. I. In Vitro Percutaneous Absorption: Principles, Fundamentals, and Applications. CRC Press, Boca Raton, FL 1991; 26
- Smith E. W., Maibach H. I. Percutaneous Penetration Enhancers. CRC Press, Boca Raton, FL 1995; 9
- Walters K. A., Hadgraft J. Pharmaceutical Skin Permeation Enhancement. Marcel Dekker, New York 1993; 383
- Ma X., Taw J., Chiang C. M. Int. J. Pharm. 1996; 142: 115
- Lipp R. J. Pharm. Pharmacol. 1999; 50: 1343